ID

34472

Description

Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01040624

Lien

https://clinicaltrials.gov/show/NCT01040624

Mots-clés

  1. 17/01/2019 17/01/2019 -
  2. 27/05/2019 27/05/2019 -
Détendeur de droits

see on clinicaltrials.gov

Téléchargé le

17 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Prostate Cancer NCT01040624

Eligibility Prostate Cancer NCT01040624

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
* adenocarcinoma of the prostate.
Description

ID.1

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous prostate cancer treatment such as chemotherapy and/or pelvic radiation.
Description

ID.2

Type de données

boolean

active inflammatory bowel disease (diverticulitis, crohn's disease or ulcerative colitis) affecting the rectum. (non-active diverticulitis and crohn's disease not affecting the rectum are allowed.)
Description

ID.3

Type de données

boolean

history of hip replacement.
Description

ID.4

Type de données

boolean

prior intrapelvic surgery. this includes the following:
Description

ID.5

Type de données

boolean

transrectal or rectal surgery other than polypectomy or hemorrhoid removal or banding
Description

ID.6

Type de données

boolean

transabdominal pelvic surgery
Description

ID.7

Type de données

boolean

bladder surgery
Description

ID.8

Type de données

boolean

prior mi (myocardial infarction) or chf (congestive heart failure).
Description

ID.9

Type de données

boolean

taking saw palmetto or methotrexate and unable or unwilling to discontinue its use during radiation.
Description

ID.10

Type de données

boolean

Similar models

Eligibility Prostate Cancer NCT01040624

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
* adenocarcinoma of the prostate.
boolean
Item Group
C0680251 (UMLS CUI)
ID.2
Item
previous prostate cancer treatment such as chemotherapy and/or pelvic radiation.
boolean
ID.3
Item
active inflammatory bowel disease (diverticulitis, crohn's disease or ulcerative colitis) affecting the rectum. (non-active diverticulitis and crohn's disease not affecting the rectum are allowed.)
boolean
ID.4
Item
history of hip replacement.
boolean
ID.5
Item
prior intrapelvic surgery. this includes the following:
boolean
ID.6
Item
transrectal or rectal surgery other than polypectomy or hemorrhoid removal or banding
boolean
ID.7
Item
transabdominal pelvic surgery
boolean
ID.8
Item
bladder surgery
boolean
ID.9
Item
prior mi (myocardial infarction) or chf (congestive heart failure).
boolean
ID.10
Item
taking saw palmetto or methotrexate and unable or unwilling to discontinue its use during radiation.
boolean

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial